Sandru A, Bordea C I, Voinea S C, Gherghe M, Albert P, Condrea I, Blidaru A
Clinica de Chirurgie Oncologică II, Institutul Oncologic, Bucureşti, România.
Chirurgia (Bucur). 2011 May-Jun;106(3):301-8.
Malignant melanoma is a disease with an unpredictable evolution. Detected in stage I and II has a great chance to cure, if it is correctly treated: excisional biopsy with safety margins in accordance with tumor thickness. Lymphoscintigraphy with sentinel node identification and biopsy became compulsory for staging malignant melanoma, the role of complete lymphadenectomy would be established by publishing the MSLTII data. The sentinel node is analysed using more and more sophisticated techniques (RT-PCR) in order to detect isolated tumoral cells, although their clinical significance is not known yet. Metastases occurrence is a dramatic phenomenon because chemotherapy, radiotherapy or biologic therapy have insignificant results. The only therapeutic modality which may increase survival in this situation is surgery for some carefully selected patients.
恶性黑色素瘤是一种发展不可预测的疾病。如果得到正确治疗,在I期和II期被检测到的恶性黑色素瘤有很大的治愈机会:根据肿瘤厚度进行带安全切缘的切除活检。用于前哨淋巴结识别和活检的淋巴闪烁显像术已成为恶性黑色素瘤分期的必要手段,完整淋巴结切除术的作用将通过公布MSLTII数据来确定。为了检测孤立肿瘤细胞,越来越多地使用复杂技术(逆转录聚合酶链反应)对前哨淋巴结进行分析,尽管其临床意义尚不清楚。转移的发生是一个严重的现象,因为化疗、放疗或生物治疗效果不佳。在这种情况下,唯一可能提高生存率的治疗方式是对一些经过精心挑选的患者进行手术。